LCP
ABBV icon

Lamond Capital Partners’s AbbVie ABBV Stock Holding History

Lamond Capital Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-250,000
Closed -$14.3M – 1
2016
Q1 		$14.3M Sell
250,000
-50,000
-17% -$2.79M 100% 1
2015
Q4 		$17.8M Buy
+300,000
New +$17.3M 26.56% 2

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Lamond Capital Partners's ABBV Position: Q2 2016 in Review

Lamond Capital Partners sold out of AbbVie (ABBV) in Q2 2016, closing a stake of 250,000 shares — an estimated $14.3M sold.

Lamond Capital Partners first reported a position in ABBV in Q4 2015 and held it in 2 quarters. The position peaked at $17.8M in Q4 2015. 1,634 funds tracked by Wall St. Rank hold ABBV as of Q2 2016.

  • Lamond Capital Partners reported no remaining AbbVie position as of Q2 2016 after selling out during the quarter.
  • Lamond Capital Partners sold 250,000 AbbVie shares in Q2 2016, an estimated $14.3M.
  • Lamond Capital Partners first reported a position in AbbVie in Q4 2015 and held it in 2 quarters.
  • Lamond Capital Partners's AbbVie position peaked at $17.8M in Q4 2015.
  • 1,634 funds tracked by Wall St. Rank held AbbVie as of Q2 2016.

Based on Lamond Capital Partners's 13F filing for Q2 2016.